Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2005
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652802A Methods of treating necrotizing enterocolitis
08/10/2005CN1652789A Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652698A Method and dietary composition for improving lipid digestibility
08/10/2005CN1652697A Method and dietary composition for improving fat digestibility
08/10/2005CN1652696A Method of improving absorption of vitamin E by a pet animal
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1651395A Borneol fatly acid ester derivative and preparation containing said derivative
08/10/2005CN1651036A Angelica root mistletoe granules and its preparation method
08/10/2005CN1651033A Chinese medicinal composition for treating gynecopathy
08/10/2005CN1651014A Chinese medicinal preparation for treating rheumatic and homologus rheumatic artbritis
08/10/2005CN1651011A Chinese medicinal composition for warming and transforming stasis, dispelling dampness and dispersing swell
08/10/2005CN1651004A Compound ginseng tea preparation for treating chronic pelvic cavity inflammation and its preparation method
08/10/2005CN1650976A Compound saussurea involucrata capsule and its preparation process
08/10/2005CN1650959A Wine for dispelling wind and removing obstruction in channels and its preparation method
08/10/2005CN1650945A Chinese medicine for treating kidney vacuity lumbar pain and preparation method of its capsule
08/10/2005CN1650941A Plaster for treating knocks and falls, and osteopathia
08/10/2005CN1650932A Tetany resolving tincture
08/10/2005CN1650929A Preparation for free flowing ginew and bone and its preparation method
08/10/2005CN1650923A Medicinal composition for treating theumalism and rheumatism diseases
08/10/2005CN1650899A Method of extracting compound pain relieving medicament from natural plant effective component
08/10/2005CN1650897A Method of extracting heat clearing toxin resoluing medicine from natural plant Chinese medicine effective component
08/10/2005CN1650890A Child metho kahuangmin effervescent granules and its making method
08/10/2005CN1650888A Povidone-iodine suppository for treating dairy cattle endometritis
08/10/2005CN1214043C Humanized antibodies to gamma-interferon
08/10/2005CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof
08/10/2005CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213980C Vitamin D analogues
08/10/2005CN1213767C Topical compositions comprising ascomycins
08/10/2005CN1213752C Treating allergic and inflammatory diseases
08/10/2005CN1213748C Composition containing unionized surfactant and active component and application thereof
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/10/2005CN1213733C Method of preparing stable suspension of insoluble microparticles
08/10/2005CN1213726C Resorcinol compsn.
08/09/2005US6927238 Lipoxin analogs; antiinflammatory activity
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927222 Compounds
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6927218 Aryl N-cyanoguanidines and methods related thereto
08/09/2005US6927216 Treatment of inflammatory disorders
08/09/2005US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects
08/09/2005US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005US6926178 Valve with a two-component seal
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2168012C Polymeric matrices and their uses in pharmaceutical compositions
08/09/2005CA2095659C Heteroatoms-containing tricyclic compounds
08/06/2005CA2464205A1 Use of ricin oil as anti-inflammatory agent
08/04/2005WO2005070133A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2004080385A3 Compositions and methods for diagnosing and treating an inflammation
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171345 Pteridine compounds for the treatment of psoriasis
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171154 Carboxylic acid amides
08/04/2005US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
08/04/2005US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders
08/04/2005US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis
08/04/2005US20050171128 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171117 Preparation of pharmaceutical salts
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171102 Semicarbazide derivatives for combating thromboembolic diseases
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171094 Pyrrolopyrimidine derivatives
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/04/2005US20050171083 Modified release pharmaceutical formulation
08/04/2005US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives